Somatically acquired biallelic MLH1 methylation in CRC results in loss of immunohistochemical expression of the MLH1 and PMS2 DNA mismatch repair (MMR) proteins and microsatellite instability within the tumour (i.e. MMR-deficiency). The gene discussed is MLH1; the disease is hyperinsulinemic hypoglycemia, familial, 4.